Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.
暂无分享,去创建一个
[1] J. Newman. Copyright and Bedside Cognitive Testing: Why We Need Alternatives to the Mini-Mental State Examination. , 2015, JAMA internal medicine.
[2] Nicholas Bagley,et al. Protection or harm? Suppressing substance-use data. , 2015, The New England journal of medicine.
[3] Jeffrey Cummings,et al. Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect , 2010, Annals of neurology.
[4] R. Thisted,et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis , 2006, Annals of neurology.
[5] R. Thisted,et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine , 2004, Neurology.